Surmodics, Inc. (DELISTED) (SRDX:DL)
Surmodics Market Cap: 614.51M for Nov. 28, 2025
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Celldex Therapeutics, Inc. | 1.872B |
| Atossa Therapeutics, Inc. | 109.80M |
| Abeona Therapeutics, Inc. | 296.43M |
| Kiora Pharmaceuticals, Inc. | 7.797M |
| Intellia Therapeutics, Inc. | 1.085B |
Market Cap Related Metrics
| PS Ratio | 5.068 |
| PEG Ratio | -0.03 |
| Price to Book Value | 5.521 |
| Price | 42.98 |
| Earnings Yield | -2.88% |
| PEGY Ratio | -0.03 |
| Operating PE Ratio | 1200.47 |